Immunotherapy in HER2-positive breast cancer: state of the art and future perspectives.
Krasniqi E, Barchiesi G, Pizzuti L, Mazzotta M, Venuti A, Maugeri-Saccà M, Sanguineti G, Massimiani G, Sergi D, Carpano S, Marchetti P, Tomao S, Gamucci T, De Maria R, Tomao F, Natoli C, Tinari N, Ciliberto G, Barba M, Vici P.
Krasniqi E, et al. Among authors: sergi d.
J Hematol Oncol. 2019 Oct 29;12(1):111. doi: 10.1186/s13045-019-0798-2.
J Hematol Oncol. 2019.
PMID: 31665051
Free PMC article.
Review.